Revised Costa Rica Outline This outline is less detailed but contains all of the info on the previous one. I just structured it differently and added a few more sources and a little more info. I. Introduction A. Biodiversity statistics B. Why biodiversity of rainforest is so important for medicine II. Specimen collection approaches A. Biodiversity-based approach B. Using interactions between organisms and chemotaxic relationships C. Ethnobotanical approach III. Process after collection A. Shipping to drug companies and research organizations B. Trials and approval by FDA IV. Searching for anti-cancer drugs A. Importance of rainforest for finding cure to cancer B. Some anti-cancer drugs already discovered C. Promising anti-cancer products today V. Searching for AIDS drugs A. Some AIDS drugs already discovered B. Some promising AIDS drugs today VI. Other important rainforest plants used for medicine VII. Why some do not believe rainforest is the place to look for new drugs A. Could lead to further destruction of rainforest B. Other techniques are faster and cheaper VIII. Conclusion Resources: Balck, Elisabetsky, and Laird. Medicinal Resources of the Tropical Forest. Columbia University Press: New York, 1996.
Joyce, Christopher. Earthly Goods. Little, Brown and Company: Boston, 1994.
Iwu, Duncan, and Okunji. "New antimicrobials of plant origin." Perspectives on New Crops and New Uses. ASHS Press: Alexandria, 1999.
"Medicinal treasures of the rainforest." Rainforest Action Network. 2002. 3 Mar. 2003. http://www.ran.org/info_center/factsheets/05f.html.
Taylor, Leslie. "Plant based drugs and medicines." Raintree Nutrition, Inc. 13 Oct. 2000. 12 Mar. 2003. http://www.rain-tree.com/plantdrugs.htm.
"Saving what remains." Mongabay.com. 2002. 12 Mar. 2003. http://www.mongabay.com/1007.htm.
"National Biodiversity Inventory." National Inventory of Biodiversity(INBIO). 12 Mar. 2003. http://www.inbio.ac.cr/en/invn/Invent.html.
Carr, Thomas A. and Heather L. Pedersen. "Rain forest entrepreneurs." Environment. Sept. 1993: 12.
"Questions and answers about NCI's natural products branch." National Cancer Institute (NCI). 1 May 2000. 12 Mar. 2003. Online. http://cis.nci.nih.gov/fact/7_33.htm.
Yoon, Carol K. "Drugs from Bugs." Garbage. Sum 1994: 22.
Tulp, Martin and Lars Bohlin. “Functional versus chemical diversity: Is biodiversity important for drug discovery?” Trends in Pharmacological Sciences. 1 May 2002: 225.
Service, Robert. “Drug industry looks to the lab instead of rainforest and reef.” Science. 9 July 1999: 186.
Soejarto, Djaja D. “Biodiversity prospecting and benefit-sharing: perscpectives from the field.” Journal of Ethnopharmacology. 1996: 1.